Biosimilars....

After my M Tech from BITS Pilani, i got placed with biotech pharma R&D where in i was asked to choose my task from being a molecular biologist to fermentation and further downstream processing. I chose to be a molecular biologist, then went ahead for Pharma consulting and the journey still continues. I have been working in the Biosimilar arena for around 8 years with experience in working in R&D to CI in terms of PMR services in terms of development of specific recombinant proteins and Mabs

In the late 2000's some big pharma companies showed a big picture to the world related to their huge investment in this arena and there were some who slowly started developing their pipeline. With the block buster era loosing its glory...biosimilars will mark the difference and emerging markets will be the bait for the big pharma's....in present Europe has been the front runner for biosimilar promotion but we can't negate the emerging markets (China, India and South Korea).....they are the new junctures for growth and promotions of biosimilars and will emerge as destination for biosimilar developments.......